Hematologic
Relationships That Fuel Research
Our mobile, direct-to-patient approach gives you access to the difficult-to-reach populations affected by these debilitating disorders. You’ll get an all-inclusive view of each patient in your study-meaning you’ll collect more accurate data points related to the complex differences seen on an individual level. Moreover, Sanguine’s emphasis on establishing trust ensures long-term patient participation and study completion.
- Amyloidosis
- Idiopathic Thrombocytopenic Purpura (ITP)
- Sickle Cell Disease (SCD)
- Thrombotic Thrombocytopenic Purpura (TTP)
Contact us to discuss your research needs
Sanguine Services
- Whole Blood
- Serum/Plasma
- DNA/RNA
- PBMCs (+ Derivatives)
- Buffy Coat
- PBMC isolation
- Serum and plasma isolation
- T cell isolation
- B cell isolation
- Natural killer cell isolation
- Genotype
- Blood Type
- Family History
- Hospitalization status
- No treatment
- Disease Confirmation
- Covid-19 (PCR)
- Sickle Cell
- HIV/HPV/Hepatitis/Herpes Etc.
- BioMarker Quantification
- CBC, Platelett, & Diff
- CRP
- Cal-Protecin
- ANA
- Cytokine Panel
- BUN
- Urinalysis
- Thyroid Stimulating Hormone
- Lipid Panel
- LDH
- Genetic Analysis
- HLA Typing
- dsDNA
- RNA Vial Load
Quantification - HBV Genotyping
- Vaso-occlusive crisis (VOC) events (Sickle cell disease)
- Longitudinal
- Sickle cell disease studies - exclude disease-modifying therapies